HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,490.00
+105.00 (2.39%)
At close: Apr 29, 2026
4.42%
Market Cap 131.55B
Revenue (ttm) 130.51B
Net Income (ttm) 252.62M
Shares Out 30.00M
EPS (ttm) 8.42
PE Ratio 11.41
Forward PE n/a
Dividend 35.00 (0.79%)
Ex-Dividend Date Apr 2, 2026
Volume 101,840
Average Volume 52,942
Open 4,350.00
Previous Close 4,385.00
Day's Range 4,350.00 - 4,525.00
52-Week Range 3,965.00 - 5,420.00
Beta 0.82
RSI 58.96
Earnings Date Apr 30, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 341
Stock Exchange KOSDAQ
Ticker Symbol 052260
Full Company Profile

Financial Performance

In 2025, HYUNDAI BIOLAND's revenue was 130.51 billion, an increase of 9.19% compared to the previous year's 119.52 billion. Earnings were 252.62 million, a decrease of -95.57%.

Financial Statements

News

There is no news available yet.